Chemical constituents of Cyperus rotundus L. and their inhibitory effects on uterine fibroids
Abstract
Background: Xiang Fu (Cyperus rotundus L) enters the liver, spleen and triple warmer meridians, and has qi stagnation-removing, qi circulation-promoting, menstruation-regulating and pain-relieving effects. Besides, it can improve ovarian function, and has hypolipidemic, hypoglycemic and neuroprotective actions.
Objectives: To study the biflavone constituents in Cyperus rotundus L and to investigate the effect and mechanism of amentoflavone on inhibition of uterine tumors. Modern chromatographic techniques were applied for isolation and purification of compounds, which were then structurally elucidated based on their physicochemical properties and spectral data.
Methods: Female SD rats were injected with diethylstilbestrol and progesterone to establish the pathological model of uterine fibroids. The rats were then randomly divided into amentoflavone high-, medium- and low-dose groups, mifepristone group, model group and blank control group (n=10 in each group), and these administered for six consecutive weeks. 24 h after the last administration, the rats were sacrificed, changes in uterine coefficient were observed, and morphological features of apoptotic cells in uterine smooth muscle tissues were detected. Afterwards, serum estradiol and progesterone levels were determined by radioimmunoassay, as well as NOS level in uterine fibroid tissue homogenates. Pro- and anti-apoptotic genes Bcl-2 and Bax were determined by immunohistochemical assay.
Results: Four biflavone constituents were isolated and obtained. Amentoflavone could markedly reduce the uterine coefficient in model rats, lower serum estrogen levels in rats with uterine fibroids, improve the pathological conditions of uterine tissues, markedly reduce the number of Bcl-2- and Bax-positive dots in smooth muscles, and significantly inhibit the tumor-like proliferation in model rats (P<0.01), which were most obvious in the amentoflavone high-dose group.
Conclusion: It concludes that amentoflavone has a significant inhibitory effect on uterine tumors in rats. Its mechanism may be by elevating Bax protein expression, down-regulating Bcl-2 expression, forming homodimers Bax/Bax, and reducing plasma estradiol and progesterone to promote apoptosis of uterine fibroid cells.
Keywords: Cyperus rotundus L., biflavone, chemical constituent, anti-tumor
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
